CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential

Wenxin Zhang1, Yuxi He1, Yan Zhang2

  • 1Department of Ophthalmology, 2nd Hospital of Jilin University, Changchun 130041, Jilin, China.

Pharmacological Research
|October 5, 2023
PubMed

Insights

Circular RNAs (circRNAs) show promise for managing ocular neovascular diseases (ONDs). This review explores circRNAs

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Ocular neovascular diseases (ONDs) cause significant vision impairment and blindness due to abnormal blood vessel growth.
  • Circular RNAs (circRNAs), non-coding RNAs, are increasingly recognized for their roles in biological processes, including angiogenesis.
  • Their association with ONDs makes them a key research focus for diagnosis and treatment.

Purpose of the Study:

  • To review the potential of circRNAs in the management of ONDs.
  • To elucidate the regulatory roles of circRNAs in the five phases of angiogenesis.
  • To analyze circRNA interactions in specific ONDs and their diagnostic potential.

Main Methods:

  • Literature review focusing on circRNAs and ONDs.
  • Analysis of circRNA regulation in angiogenesis.
  • Detailed examination of circRNAs in pterygium, corneal neovascularization, age-related macular degeneration, diabetic retinopathy, and retinopathy of prematurity.

Main Results:

  • CircRNAs play a regulatory role in angiogenesis, offering potential therapeutic targets.
  • Specific circRNAs are implicated in various ONDs, demonstrating their disease association.
  • CircRNAs show potential as diagnostic biomarkers for ONDs.

Conclusions:

  • CircRNAs represent a promising avenue for OND management strategies.
  • Further research is needed to bridge the gap between current findings and clinical applications.
  • Harnessing circRNAs could lead to novel diagnostic and therapeutic approaches for vision-threatening diseases.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
604
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
546
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
472
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K